JAGX
Jaguar Health (JAGX)
$
25About Jaguar Health (JAGX)
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Details
Daily high
$1.29
Daily low
$1.24
Price at open
$1.25
52 Week High
$30.86
52 Week Low
$0.95
Market cap
11.6M
Dividend yield
0.00%
Volume
5,039
Avg. volume
313,446
P/E ratio
-.03
Jaguar Health News
Details
Daily high
$1.29
Daily low
$1.24
Price at open
$1.25
52 Week High
$30.86
52 Week Low
$0.95
Market cap
11.6M
Dividend yield
0.00%
Volume
5,039
Avg. volume
313,446
P/E ratio
-.03